Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MGA Magna International	$65.21 +0.7%	$59.59	$35.34 ▼ $69.94	$17.75B	1.43	1.80 million shs	987,897 shs
NVDA NVIDIA	$224.31 +6.2%	$199.28	$135.40 ▼ $236.54	$5.43T	2.22	171.69 million shs	176.41 million shs
RHHBY Roche	$50.17 -4.3%	$50.68	$37.51 ▼ $60.85	$319.61B	0.5	2.55 million shs	3.09 million shs
RXRX Recursion Pharmaceuticals	$3.80 +5.7%	$3.27	$2.77 ▼ $7.18	$2.01B	1.04	17.01 million shs	28.64 million shs
SERV Serve Robotics	$9.50 +1.6%	$8.90	$7.66 ▼ $18.64	$734.63M	0.55	4.95 million shs	6.80 million shs
SHAK Shake Shack	$62.35 -3.0%	$84.60	$59.49 ▼ $144.65	$2.67B	1.63	1.74 million shs	1.62 million shs
SNY Sanofi	$42.94 -1.7%	$45.62	$42.33 ▼ $52.68	$104.11B	0.34	3.59 million shs	2.38 million shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MGA Magna International	0.00%	+0.34%	+1.89%	+2.53%	+78.50%
NVDA NVIDIA	0.00%	-1.95%	+5.80%	+15.71%	+57.24%
RHHBY Roche	0.00%	-1.76%	+2.99%	-9.45%	+29.86%
RXRX Recursion Pharmaceuticals	0.00%	+19.27%	+3.76%	-1.10%	-14.52%
SERV Serve Robotics	0.00%	+7.47%	-0.85%	-6.50%	-18.77%
SHAK Shake Shack	0.00%	+2.41%	-37.36%	-31.96%	-50.55%
SNY Sanofi	0.00%	-1.40%	-6.25%	-8.37%	-11.60%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MGA Magna International	$65.21 +0.7%	$59.59	$35.34 ▼ $69.94	$17.75B	1.43	1.80 million shs	987,897 shs
NVDA NVIDIA	$224.31 +6.2%	$199.28	$135.40 ▼ $236.54	$5.43T	2.22	171.69 million shs	176.41 million shs
RHHBY Roche	$50.17 -4.3%	$50.68	$37.51 ▼ $60.85	$319.61B	0.5	2.55 million shs	3.09 million shs
RXRX Recursion Pharmaceuticals	$3.80 +5.7%	$3.27	$2.77 ▼ $7.18	$2.01B	1.04	17.01 million shs	28.64 million shs
SERV Serve Robotics	$9.50 +1.6%	$8.90	$7.66 ▼ $18.64	$734.63M	0.55	4.95 million shs	6.80 million shs
SHAK Shake Shack	$62.35 -3.0%	$84.60	$59.49 ▼ $144.65	$2.67B	1.63	1.74 million shs	1.62 million shs
SNY Sanofi	$42.94 -1.7%	$45.62	$42.33 ▼ $52.68	$104.11B	0.34	3.59 million shs	2.38 million shs

A Guide To High-Short-Interest Stocks

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MGA Magna International	0.00%	+0.34%	+1.89%	+2.53%	+78.50%
NVDA NVIDIA	0.00%	-1.95%	+5.80%	+15.71%	+57.24%
RHHBY Roche	0.00%	-1.76%	+2.99%	-9.45%	+29.86%
RXRX Recursion Pharmaceuticals	0.00%	+19.27%	+3.76%	-1.10%	-14.52%
SERV Serve Robotics	0.00%	+7.47%	-0.85%	-6.50%	-18.77%
SHAK Shake Shack	0.00%	+2.41%	-37.36%	-31.96%	-50.55%
SNY Sanofi	0.00%	-1.40%	-6.25%	-8.37%	-11.60%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MGA Magna International	2.40	Hold	$63.13	-3.20% Downside
NVDA NVIDIA	3.00	Buy	$305.38	36.14% Upside
RHHBY Roche	2.45	Hold	$51.50	2.65% Upside
RXRX Recursion Pharmaceuticals	2.20	Hold	$8.10	113.44% Upside
SERV Serve Robotics	2.67	Moderate Buy	$17.51	84.46% Upside
SHAK Shake Shack	2.54	Moderate Buy	$106.83	71.34% Upside
SNY Sanofi	2.47	Hold	$51.00	18.77% Upside

Current Analyst Ratings Breakdown

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/1/2026	NVDA NVIDIA	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$300.00
5/29/2026	MGA Magna International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
5/27/2026	NVDA NVIDIA	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Strong-Buy	$360.00 ➝ $425.00
5/27/2026	NVDA NVIDIA	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Strong-Buy	$360.00 ➝ $425.00
5/27/2026	SHAK Shake Shack	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$76.00 ➝ $70.00
5/26/2026	NVDA NVIDIA	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$280.00 ➝ $300.00
5/22/2026	NVDA NVIDIA	Citic Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$242.00 ➝ $315.00
5/22/2026	NVDA NVIDIA	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$215.00 ➝ $255.00
5/22/2026	NVDA NVIDIA	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$240.60 ➝ $268.30
5/21/2026	NVDA NVIDIA	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform	$300.00 ➝ $500.00
5/21/2026	NVDA NVIDIA	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$250.00 ➝ $335.00

(Data available from 6/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MGA Magna International	$42.01B	0.42	$11.86 per share	5.50	$45.81 per share	1.42
NVDA NVIDIA	$215.94B	25.14	$5.02 per share	44.69	$6.47 per share	34.67
RHHBY Roche	$76.45B	4.18	$3.45 per share	14.55	$7.18 per share	6.99
RXRX Recursion Pharmaceuticals	$74.68M	26.93	N/A	N/A	$2.14 per share	1.77
SERV Serve Robotics	$2.65M	277.22	N/A	N/A	$4.71 per share	2.02
SHAK Shake Shack	$1.45B	1.85	$3.82 per share	16.33	$12.97 per share	4.81
SNY Sanofi	$49.35B	2.11	$6.95 per share	6.18	$33.26 per share	1.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MGA Magna International	$829M	$2.39	27.28	8.37	0.88	1.60%	14.01%	5.53%	7/31/2026 (Estimated)
NVDA NVIDIA	$120.07B	$6.53	34.35	20.62	0.51	62.97%	96.94%	72.16%	N/A
RHHBY Roche	$15.55B	N/A	N/A	14.29	4.31	N/A	N/A	N/A	7/23/2026 (Estimated)
RXRX Recursion Pharmaceuticals	-$644.76M	-$1.20	N/A	N/A	N/A	-842.95%	-54.33%	-40.60%	8/4/2026 (Estimated)
SERV Serve Robotics	-$101.36M	-$2.01	N/A	N/A	N/A	-2,639.98%	-47.31%	-44.89%	8/6/2026 (Estimated)
SHAK Shake Shack	$45.72M	$0.98	63.62	40.49	2.70	2.76%	9.62%	2.81%	7/30/2026 (Estimated)
SNY Sanofi	$8.84B	$3.58	11.99	8.24	1.08	16.95%	13.39%	7.58%	7/30/2026 (Estimated)

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/20/2026	Q1 2027	NVDA NVIDIA	$1.76	$1.87	+$0.11	$2.39	$78.42 billion	$81.62 billion
5/7/2026	Q1 2026	SERV Serve Robotics	-$0.5667	-$0.65	-$0.0833	-$0.65	$2.83 million	$2.98 million
5/7/2026	Q1 2026	SHAK Shake Shack	$0.11	-$0.0015	-$0.1115	-$0.01	$372.43 million	$366.74 million
5/6/2026	Q1 2026	RXRX Recursion Pharmaceuticals	-$0.30	-$0.22	+$0.08	-$0.22	$15.78 million	$6.47 million
5/1/2026	Q1 2026	MGA Magna International	$1.01	$1.38	+$0.37	-$0.04	$10.14 billion	$10.13 billion
3/12/2026	Q4 2025	SERV Serve Robotics	-$0.49	-$0.46	+$0.03	-$0.46	$0.77 million	$0.88 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MGA Magna International	$1.98	3.04%	-9.47%	82.85%	6 Years
NVDA NVIDIA	$0.04	0.02%	+14.87%	0.61%	1 Years
RHHBY Roche	$0.97	1.93%	N/A	N/A	N/A
RXRX Recursion Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SERV Serve Robotics	N/A	N/A	N/A	N/A	N/A
SHAK Shake Shack	N/A	N/A	N/A	N/A	N/A
SNY Sanofi	$1.76	4.10%	+6.46%	49.16%	N/A

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/20/2026	NVDA NVIDIA	quarterly	$0.25	0.45%	6/4/2026	6/4/2026	6/26/2026
4/14/2026	SNY Sanofi	annual	$2.4225	5.59%	5/4/2026	5/4/2026	6/3/2026
5/1/2026	MGA Magna International	quarterly	$0.4950	3.28%	5/15/2026	5/15/2026	5/29/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MGA Magna International	0.38	1.22	0.88
NVDA NVIDIA	0.04	3.44	2.85
RHHBY Roche	0.72	1.38	1.12
RXRX Recursion Pharmaceuticals	0.01	5.47	5.47
SERV Serve Robotics	N/A	10.19	10.19
SHAK Shake Shack	0.45	1.69	1.66
SNY Sanofi	0.17	1.01	0.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MGA Magna International	67.49%
NVDA NVIDIA	65.27%
RHHBY Roche	N/A
RXRX Recursion Pharmaceuticals	89.06%
SERV Serve Robotics	N/A
SHAK Shake Shack	86.07%
SNY Sanofi	14.03%

Insider Ownership

Company	Insider Ownership
MGA Magna International	0.50%
NVDA NVIDIA	3.94%
RHHBY Roche	N/A
RXRX Recursion Pharmaceuticals	8.43%
SERV Serve Robotics	5.00%
SHAK Shake Shack	8.32%
SNY Sanofi	1.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MGA Magna International	156,000	272.23 million	270.86 million	Optionable
NVDA NVIDIA	42,000	24.20 billion	23.25 billion	Optionable
RHHBY Roche	103,249	6.37 billion	N/A	Not Optionable
RXRX Recursion Pharmaceuticals	400	529.91 million	485.23 million	Optionable
SERV Serve Robotics	67	77.37 million	73.50 million	N/A
SHAK Shake Shack	13,873	42.78 million	39.22 million	Optionable
SNY Sanofi	74,846	2.42 billion	2.40 billion	Optionable

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Headlines

Recent News About These Companies

FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug

May 29 at 11:01 AM | zacks.com

Sanofi: Sanofi's venglustat accepted for priority review in the US to treat type 3 Gaucher disease

May 28, 2026 | finanznachrichten.de

Press Release: Sanofi's venglustat accepted for priority review in the US to treat type 3 Gaucher disease

May 28, 2026 | globenewswire.com

Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails

May 22, 2026 | zacks.com

sanofi - SNY

May 21, 2026 | foxbusiness.com

Sanofi: Information concerning the total number of voting rights and shares - April 2026

May 19, 2026 | globenewswire.com

Teva Stock Up More Than 100% in a Year: Time to Buy, Hold or Sell?

May 19, 2026 | zacks.com

Sanofi says rare lung disease drug outperforms standard care in trial

May 18, 2026 | reuters.com

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD

May 18, 2026 | globenewswire.com

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

May 13, 2026 | fool.com

Erste Group Bank Decreases Earnings Estimates for Sanofi

May 11, 2026 | marketbeat.com

DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects

May 8, 2026 | zacks.com

Truist Financial Corp Sells 37,780 Shares of Sanofi $SNY

May 7, 2026 | marketbeat.com

Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports

May 6, 2026 | reuters.com

Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1

May 6, 2026 | prnewswire.com

Sanofi $SNY Shares Sold by UBS Group AG

May 6, 2026 | marketbeat.com

Sanofi (NASDAQ:SNY) Sets New 1-Year Low - Should You Sell?

May 5, 2026 | marketbeat.com

Sanofi (NASDAQ:SNY) Shares Gap Down Following Analyst Downgrade

May 4, 2026 | marketbeat.com

M&T Bank Corp Sells 402,012 Shares of Sanofi $SNY

May 3, 2026 | marketbeat.com

Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi

April 29, 2026 | globenewswire.com

Giants Costco, Sanofi, and SAP Raise Dividends by Over 10% (SNY)

...

April 28, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Company Descriptions

Magna International NYSE:MGA

$65.21 +0.45 (+0.70%)

Closing price 03:59 PM Eastern

Extended Trading

$65.14 -0.07 (-0.11%)

As of 04:10 PM Eastern

Magna International Inc. designs, engineers, and manufactures components, assemblies, systems, subsystems, and modules for original equipment manufacturers of vehicles and light trucks worldwide. It operates through four segments: Body Exteriors & Structures, Power & Vision, Seating Systems, and Complete Vehicles. The Body Exteriors & Structures segment provides body and chassis system, battery enclosures, and engineering and testing; and exteriors, including fascia and trims, front end modules, integration panels, liftgate modules, active aerodynamics, engineered glass, running boards, truck bed access products, breakthrough lightings, side doors, and greenhouse products. The Power & Vision segment offers electric drive systems and components, such as emotors, inverters, onboard chargers, gearboxes, and e-clutch; dedicated hybrid drives, dual and hybrid dual clutch, and manual transmissions; AWD/4WD products and rear drive modules; transmission, driveline components, and ICE; far camera module, remote camera heads, interior sensing camera, radars, thermal sensing, and domain controllers; interior and exterior mirrors, camera monitoring system driver/occupant monitoring systems, and smart actuators; forward and rear lighting, and lit grilles/panels/displays; latching system, door modules, charge port doors, power system, hinges, and door handles; and modular and textile folding roofs, and hard and soft tops. The Seating Systems segment provides seat structures, mechanism and hardware solutions, and foam and trim products. The Complete Vehicles segment offers vehicle engineering and manufacturing services. Magna International Inc. was founded in 1957 and is headquartered in Aurora, Canada.

NVIDIA NASDAQ:NVDA

$224.31 +13.17 (+6.24%)

Closing price 03:59 PM Eastern

Extended Trading

$224.63 +0.32 (+0.14%)

As of 04:14 PM Eastern

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

Roche OTCMKTS:RHHBY

$50.17 -2.23 (-4.26%)

As of 03:53 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Recursion Pharmaceuticals NASDAQ:RXRX

$3.80 +0.21 (+5.71%)

Closing price 03:59 PM Eastern

Extended Trading

$3.78 -0.02 (-0.40%)

As of 04:13 PM Eastern

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Serve Robotics NASDAQ:SERV

$9.49 +0.15 (+1.55%)

Closing price 03:59 PM Eastern

Extended Trading

$9.48 -0.02 (-0.17%)

As of 04:14 PM Eastern

Serve Robotics Inc. designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. It builds self-driving delivery robots. The company was formerly known as Patricia Acquisition Corp. and changed its name to Serve Robotics Inc. in July 2023. Serve Robotics Inc. was founded in 2017 and is based in Redwood City, California.

Shake Shack NYSE:SHAK

$62.35 -1.96 (-3.05%)

Closing price 03:59 PM Eastern

Extended Trading

$62.26 -0.09 (-0.15%)

As of 04:13 PM Eastern

Shake Shack Inc. owns, operates, and licenses Shake Shack restaurants (Shacks) in the United States and internationally. Its Shacks offers hamburgers, chicken, hot dogs, crinkle cut fries, shakes, frozen custard, beer, wine, and other products. The company was founded in 2001 and is headquartered in New York, New York.

Sanofi NASDAQ:SNY

$42.94 -0.73 (-1.67%)

Closing price 03:59 PM Eastern

Extended Trading

$42.97 +0.03 (+0.07%)

As of 04:10 PM Eastern

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Earnings

Compare Dividends

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Company Descriptions

Magna International NYSE:MGA

NVIDIA NASDAQ:NVDA

Roche OTCMKTS:RHHBY

Recursion Pharmaceuticals NASDAQ:RXRX

Serve Robotics NASDAQ:SERV

Shake Shack NYSE:SHAK

Sanofi NASDAQ:SNY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools